Berenson Stephen has filed 12 insider transactions across 2 companies since April 2023.
Most recent transaction: a grant/award of 11470 shares of Seres Therapeutics, Inc. ($MCRB) on July 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | Seres Therapeutics, Inc. | $MCRB | Berenson Stephen | Not found | A | Stock Option (right to buy) | 11470 | $0.00 | 11,470.0000 | 174,358,753 | 9999.99% | 0.01% |
| April 10, 2025 | Seres Therapeutics, Inc. | $MCRB | Berenson Stephen | Not found | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 174,358,753 | 9999.99% | 0.06% |
| July 1, 2024 | Seres Therapeutics, Inc. | $MCRB | Berenson Stephen | Not found | A | Stock Option (Right to Buy) | 114782 | $0.00 | 114,782.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2024 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | M | Common Stock | 732 | $0.00 | 22,203.0000 | 382,000,000 | 3.41% | 0.00% |
| May 3, 2024 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | M | Restricted Stock Units | 732 | $0.00 | 0.0000 | 382,000,000 | 100.00% | 0.00% |
| May 6, 2024 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | A | Stock Option (Right to Buy) | 7557 | $0.00 | 7,557.0000 | 382,000,000 | 9999.99% | 0.00% |
| April 4, 2024 | Seres Therapeutics, Inc. | $MCRB | Berenson Stephen | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Seres Therapeutics, Inc. | $MCRB | Berenson Stephen | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | A | Stock Option (Right to Buy) | 4601 | $0.00 | 4,601.0000 | 416,000,000 | 9999.99% | 0.00% |
| May 3, 2023 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | A | Restricted Stock Units | 732 | $0.00 | 732.0000 | 416,000,000 | 9999.99% | 0.00% |
| April 28, 2023 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | M | Common Stock | 670 | $0.00 | 21,471.0000 | 416,000,000 | 3.22% | 0.00% |
| April 28, 2023 | Moderna, Inc. | $MRNA | Berenson Stephen | Director | M | Restricted Stock Units | 670 | $0.00 | 0.0000 | 416,000,000 | 100.00% | 0.00% |